BAFNA PHARMACEUTICALS
Back to Balance Sheet
|
BAFNA PHARMACEUTICALS Last 5 Year Sundry Debtors History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Sundry Debtors | ₹40 Cr | ₹45 Cr | ₹41 Cr | ₹15 Cr | ₹9.56 Cr |
What is the latest Sundry Debtors ratio of BAFNA PHARMACEUTICALS ?
| Year | Sundry Debtors |
|---|---|
| Mar2025 | ₹40 Cr |
| Mar2024 | ₹45 Cr |
| Mar2023 | ₹41 Cr |
| Mar2022 | ₹15 Cr |
| Mar2021 | ₹9.56 Cr |
How is Sundry Debtors of BAFNA PHARMACEUTICALS Trending?
| Years | Sundry Debtors | % Change | |
|---|---|---|---|
| Mar2025 | ₹40 Cr | -11.50 | |
| Mar2024 | ₹45 Cr | 10.32 | |
| Mar2023 | ₹41 Cr | 178.41 | |
| Mar2022 | ₹15 Cr | 54.60 | |
| Mar2021 | ₹9.56 Cr | - | |
Compare Sundry Debtors of peers of BAFNA PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BAFNA PHARMACEUTICALS | ₹298.9 Cr | -10% | -15.4% | 54.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹408,019.0 Cr | -3.5% | -5.4% | -3.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹168,752.0 Cr | -3.6% | 0.2% | 11.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹135,542.0 Cr | -0.5% | 5.9% | 20.3% | Stock Analytics | |
| CIPLA | ₹115,883.0 Cr | -1.8% | -4.8% | -1.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,024.7 Cr | -1.7% | -7.3% | -12.1% | Stock Analytics | |
BAFNA PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BAFNA PHARMACEUTICALS | -10% |
-15.4% |
54.1% |
| SENSEX | -1.9% |
-2.2% |
7.4% |
You may also like the below Video Courses